Reprint
Phytochemical Omics in Medicinal Plants
Edited by
May 2021
542 pages
- ISBN978-3-0365-1294-5 (Hardback)
- ISBN978-3-0365-1293-8 (PDF)
This book is a reprint of the Special Issue Phytochemical Omics in Medicinal Plants that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
Medicinal plants are used to treat diseases and provide health benefits, and their applications are increasing around the world. A huge array of phytochemicals have been identified from medicinal plants, belonging to carotenoids, flavonoids, lignans, and phenolic acids, and so on, with a wide range of biological activities. In order to explore our knowledge of phytochemicals with the assistance of modern molecular tools and high-throughput technologies, this book collects recent innovative original research and review articles on subtopics of mechanistic insights into bioactivities, treatment of diseases, profiling, extraction and identification, and biotechnology.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
network pharmacology; traditional herbal medicine; methodological trend; polysaccharide fraction; Trichoderma atroviride; Salvia miltiorrhiza; proteomics; tanshinones; Flos Chrysanthemi indici; essential oil; extraction method; chemical composition; biological activity; Garcinia linii; hypoglycemia; benzopyran; triterpene; bioflavonoid; phenolic; in silico; neurodegenerative diseases; naringenin; pharmacological targets; signaling pathways; molecular mechanisms; drug delivery systems; luteolin; hyphenated techniques; chromatography; colorectal cancer; diterpenes; inflammatory bowel diseases; Polyalthia longifolia; herbal medicine; DESs; preparative-scale purification; flavonoids; 20-hydroxyecdysone; Chenopodium quinoa; Zinc oxide nanoparticles; anticancer; antileishmanial; antimicrobial; biocompatibility; cancer; apoptosis; herbs; cell lines; in vivo; quercetin; polyphenols; Alzheimer’s disease; mechanistic insights; clinical directions; isodon genus; ent-kaurane diterpenoids; cancer; natural compounds; pathways; medicinal plants; bioactive compounds; herbs; biological activity; 4-hydroxynonenal; deleterious effects; Asiatic acid; nasopharyngeal cancer; apoptosis; cisplatin resistance; MAPK pathway; Anthocyanin; Solanum nigrum L.; flavonoid biosynthesis; AtPAP1; licochalcone D; non-small cell lung cancer; reactive oxygen species; apoptosis; Acorus gramineusand; Euodia ruticarpa; pro-/anti-inflammatory cytokines; steam distillation essential oil; Th1/Th2 cytokines; lignans; Trachelospermum asiaticum; GNPS; targeted isolation; Rheum undulatum; Glycyrriza uralensis; hepatic encephalopathy; MMP-9; neuroinflammation; luteolin-7-O-glucoside; oral cancer; migration; invasion; MMP-2; Astragalus mongholicus; ultraviolet-B radiation; phenolics; untargeted gas chromatography-mass spectrometry; targeted liquid chromatography-mass spectrometry; Alzheimer’s disease; Bacopa monnieri; bioactive compounds; cheminformatics; neurological diseases; spinocerebellar ataxia; system pharmacology; (-)-epigallocatechin-3-gallate (EGCG); bone morphogenetic protein-2 (BMP-2); catethin; fracture healing; local use; cardiovascular diseases; inflammation; lipid metabolism; non-coding RNA; oxidative stress; phenolic compounds; Peucedanum ostruthium; Apiaceae; ELINA; HetCA, STOCSY; coumarines; NF-ĸB; VCAM-1; E-selectin; inflammation; Withaferin A; oral cancer; oxidative stress; migration; invasion; matrix metalloproteinases; antioxidant signaling; Curcuma aromatica; sesquiterpene; anti-inflammatory; luciferase assay; cytotoxicity; n/a